Literature DB >> 1519031

Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.

J L Cartel1, A Spiegel, L Nguyen Ngnoc, R Cardines, R Plichart, P M Martin, J F Roux, J P Moulia-Pelat.   

Abstract

In October 1989, 58 apparently healthy Polynesian Wuchereria bancrofti carriers, in whom microfilarial (mf) density was greater than or equal to 100 mf/ml, were randomly allocated to treatment groups receiving single doses of either ivermectin at 100 mcg/kg or diethylcarbamazine (DEC) at 3 and 6 mg/kg. Six months later, half of the carriers initially treated with ivermectin 100 mcg/kg or DEC 3 mg/kg were given a second similar dose while the rest were given a placebo. Six months later again, all of the carriers received a last treatment dose similar to the initial one. The results observed during the 12-month period which followed this last treatment have confirmed that (i) in terms of immediate clearance or complete negativation of microfilaremia, the efficacy of ivermectin is higher than that of DEC (at dosage of 3 or 6 mg/kg), (ii) DEC is more effective than ivermectin in sustaining the reduction of microfilaremia over a longer period of time and (iii) the efficacy of repeated single doses of either DEC 3 mg/kg or ivermectin 100 mcg/kg is much higher when given semi-annually than annually.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519031

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  5 in total

1.  Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.

Authors:  Benoit Dembele; Yaya I Coulibaly; Housseini Dolo; Siaka Konate; Siaka Y Coulibaly; Dramane Sanogo; Lamine Soumaoro; Michel E Coulibaly; Salif Seriba Doumbia; Abdallah A Diallo; Sekou F Traore; Adama Diaman Keita; Michael P Fay; Thomas B Nutman; Amy D Klion
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

2.  The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.

Authors:  Sébastien D S Pion; Cédric B Chesnais; Jean Bopda; Frédéric Louya; Peter U Fischer; Andrew C Majewski; Gary J Weil; Michel Boussinesq; François Missamou
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

Review 3.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

4.  A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.

Authors:  Yaya Ibrahim Coulibaly; Ilo Dicko; Modibo Keita; Mahamadou Minamba Keita; Moussa Doumbia; Adama Daou; Fadima Cheick Haidara; Moussa Hama Sankare; John Horton; Caroline Whately-Smith; Samba Ousmane Sow
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09

5.  Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.

Authors:  Jérémy T Campillo; Naomi P Awaca-Uvon; Francois Missamou; Jean-Paul Tambwe; Godefroy Kuyangisa-Simuna; Gary J Weil; Frédéric Louya; Michel Boussinesq; Sébastien D S Pion; Cédric B Chesnais
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.